PER.C6 Development Center, a joint venture of Crucell N.V. and DSM Biologics, two leading Dutch biotech companies, will move into the building by the end of the year once tenant improvements to the space are completed. The space will serve as the firm's research and development center.
"The decision to locate in Cambridge was easy because of its outstanding scientific resources and proximity to other large life science companies, as well as its world-class talent pool," Ryan Weber, with NAI Hunneman Commercial's Boston office, says in a statement.
Weber handled the transaction for the tenant, with assistance from Sean McKee of PharmaBioSource Realty. Mark Winters, with Cushman & Wakefield's Boston office, represented the landlord, Draper Laboratories, in the deal.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
